Earnings History Data for Merus (MRUS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Merus
Merus B.V. is a clinical-stage immuno-oncology company developing bispecific antibody therapeutics, referred to as Biclonics. The company's bispecific antibody candidate, MCLA-128, is being evaluated in a Phase 1/2 clinical trial as a potential treatment for HER2-expressing solid tumors; MCLA-117, is being developed as a potential treatment for acute myeloid leukemia and MCLA-158, which is designed to bind to cancer stem cells and is being developed as a potential treatment for colorectal cancer and other solid tumors. Merus B.V. is headquartered in Utrecht, the Netherlands.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-10-2024 | PM | MRUS | Merus | 3,541 | -0.95 | -0.90 | 0.00 | Merus GAAP EPS of -$1.46, revenue of $11.77M [10/31/2024 8:46 AM] |
50.03 | -1.25 (-2.44%) |
51.28 | 0.0 (0.00%) |
19.89 - 61.61 | 335,010 | 360,000 | 90,547 | ||
| 01-08-2024 | AH | MRUS | Merus | 3,132 | -0.81 | -0.76 | 0.00 | Merus GAAP EPS of -$0.81 misses by $0.05, revenue of $7.33M misses by $1.11M [8/1/2024 5:41 PM] |
52.10 | -0.32 (-0.61%) |
52.42 | 0.0 (0.00%) |
19.81 - 61.61 | 753,599 | 490,000 | 7,591 | ||
| 07-08-2023 | AH | MRUS | Merus | 1,211 | -0.66 | -0.86 | 0.00 | Merus GAAP EPS of -$0.66 beats by $0.21, revenue of $10.48M misses by $0.89M [8/7/2023 5:23 PM] |
22.94 | -2.11 (-8.42%) |
25.05 | 0.0 (0.00%) |
12.03 - 30.81 | 179,641 | 140,000 | 1,742 | ||
| 03-11-2022 | PM | Before the open (Nov 3) |
MRUS | Merus | 941.00 | -0.53 | -0.60 | 0.00 | Merus GAAP EPS of -$0.53 beats by $0.08, revenue of $6.58M misses by $4.42M [11/3/2022 9:20 AM] |
15.12 | -5.26 (-25.81%) |
13.00 | -7.38 (-36.21%) |
12.03 - 33.09 | 3,773,372 | 290,000 | 8,871 | |
| 08-08-2022 | AH | 4:30 PM ET (Aug 8) |
MRUS | Merus | 1,229 | -0.13 | -0.65 | 0.00 | Merus GAAP EPS of -$0.13 beats by $0.49, revenue of $12.68M beats by $2.23M [8/8/2022 5:38 PM] |
26.50 | -1.67 (-5.93%) |
28.17 | 0.0 (0.00%) |
13.46 - 33.09 | 508,893 | 200,000 | 983 | |
| 09-05-2022 | AH | MRUS | Merus | 806.00 | -0.43 | -0.66 | 0.00 | Merus GAAP EPS of -$0.43 beats by $0.22, revenue of $11.66M beats by $2.29M [5/9/2022 4:55 PM] |
18.36 | 1.53 (9.09%) |
16.83 | 0.0 (0.00%) |
16.14 - 33.09 | 408,394 | 190,431 | 4,165 | ||
| 02-11-2021 | AH | MRUS | Merus | 1,079 | -0.39 | -0.66 | 0.00 | 31.53 | 1.03 (3.38%) |
30.50 | 0.0 (0.00%) |
11.19 - 33.00 | 431,609 | 280,000 | 100 | |||
| 06-05-2021 | AH | MRUS | Merus N.v. | 822.00 | -0.28 | -0.22 | 0.00 | Merus EPS misses by $0.10, misses on revenue [5/6/2021 5:26 PM] |
20.31 | 0.02 (0.10%) |
0.0 | 0.0 (0.00%) |
10.18 - 31.27 | 62,485 | 70,000 | 0 | ||
| 16-03-2021 | AH | MRUS | Merus N.v. | 724.00 | -0.77 | -0.61 | 0.00 | Merus EPS misses by $0.28, beats on revenue [3/16/2021 5:15 PM] |
22.76 | -0.57 (-2.46%) |
22.68 | -0.66 (-2.83%) |
10.18 - 31.27 | 49,401 | 138,379 | 755 | ||